Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor for Hyperphosphatemia in CKD Dialysis Patients
NCT03427125Phase 3Completed
- Sponsor
- Ardelyx
- Start
- Jan 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in hyperphosphatemia, sponsored by Ardelyx. Started Jan 2018; status: completed.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT03427125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427125.